Cargando…

Adult stem cell transplantation combined with conventional therapy for the treatment of end-stage liver disease: a systematic review and meta-analysis

End-stage liver disease (ESLD) is characterized by the deterioration of liver function and a subsequent high mortality rate. Studies have investigated the use of adult stem cells to treat ESLD. Here, a systematic review and meta-analysis was conducted to determine the efficacy of a combination thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Chen-Hui, Zhang, Dian-Han, Zhu, Chen-Wei, Xu, Jing, Guo, Chuan-Long, Wu, Xiang-Gen, Cao, Qi-Long, Di, Guo-Hu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557537/ https://www.ncbi.nlm.nih.gov/pubmed/34717737 http://dx.doi.org/10.1186/s13287-021-02625-x

Ejemplares similares

Stem cell transplantation for the treatment of end-stage liver disease
por: Wu, Dong-Bo, et al.
Publicado: (2018)

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
por: Lu, Shi-Chun, et al.
Publicado: (2014)

Liver Regeneration and Cell Transplantation for End-Stage Liver Disease
por: Li, Yan, et al.
Publicado: (2021)

High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
por: Sakpal, Sujit Vijay, et al.
Publicado: (2019)

Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease
por: Huang, Changjun, et al.
Publicado: (2020)

Transplantation of Autologous Mesenchymal Stem Cells for End-Stage Liver Cirrhosis: A Meta-Analysis Based on Seven Controlled Trials
por: Ma, Xiang-Rui, et al.
Publicado: (2015)

Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer
por: Zhang, Jing, et al.
Publicado: (2017)

Erectile function in men with end-stage liver disease improves after living donor liver transplantation
por: Chien, You-Chiuan, et al.
Publicado: (2015)

The Model for End-Stage Liver Disease Score and the Follow-Up Period Can Cause the Shift of Circulating Lymphocyte Subsets in Liver Transplant Recipients
por: Pan, Fei, et al.
Publicado: (2022)

Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report
por: Tariciotti, Laura, et al.
Publicado: (2016)

Sarcopenia in Children With End‐Stage Liver Disease on the Transplant Waiting List
por: Woolfson, Jessica P., et al.
Publicado: (2021)

Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation
por: Raza, Muhammad H., et al.
Publicado: (2023)

The Influence of Diabetes Mellitus on the Risks of End-Stage Kidney Disease and Mortality After Liver Transplantation
por: Lee, Chung-Ying, et al.
Publicado: (2022)

Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
por: Tao, Ya-Chao, et al.
Publicado: (2020)

Kidney function and mortality post-liver transplant in the Model for End-Stage Liver Disease era
por: Sethi, Aastha, et al.
Publicado: (2011)

Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation
por: Cheng, Xingxing S., et al.
Publicado: (2017)

Cardiovascular manifestation of end-stage liver disease and perioperative echocardiography for liver transplantation: anesthesiologist’s view
por: Han, Sangbin, et al.
Publicado: (2022)

Prognostic Value of Model for End-Stage Liver Disease Incorporating with Serum Sodium Score for Development of Acute Kidney Injury after Liver Transplantation
por: Cheng, Yuan, et al.
Publicado: (2018)

Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria
por: Ravaioli, Matteo, et al.
Publicado: (2019)

Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure
por: Chen, Wei, et al.
Publicado: (2017)

Cell therapy in end-stage liver disease: replace and remodel
por: Hu, Xin-Hao, et al.
Publicado: (2023)

Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era
por: Klose, Johannes, et al.
Publicado: (2014)

Osseous and Nonosseous Bone Scan Findings in Liver Transplant Candidates with end-stage Chronic Liver Disease
por: Erhamamcı, Seval, et al.
Publicado: (2013)

Characterizing Heart Failure With Preserved Ejection Fraction in End-Stage Liver Disease and Liver Transplant Outcomes
por: Shin, Won-Jung, et al.
Publicado: (2023)

Cost-effectiveness analysis of liver transplantation in biliary atresia according to the severity of end-stage liver disease
por: Sihaklang, Boonyanurak, et al.
Publicado: (2023)

Validation of the Model for End-Stage Liver Disease Score Criteria in Urgent Liver Transplantation for Acute Flare Up of Hepatitis B
por: Lee, Wei-Chen, et al.
Publicado: (2016)

THE USE OF MELD SCORE (MODEL FOR END-STAGE LIVER DISEASE) AND DERIVATIVES IN CARDIAC TRANSPLANTATION
por: de MORAES, Ana Claudia Oliveira, et al.
Publicado: (2018)

Anesthetic management of lung transplantation in a patient with end-stage COVID-19 pneumonia: A case report
por: Guo, Shao-Hui, et al.
Publicado: (2021)

Comparison of the efficacy between intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in stage II nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2017)

Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control
por: Gao, Yun, et al.
Publicado: (2022)

Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study
por: Pan, Guang-hui, et al.
Publicado: (2016)

HLA Polymorphism and Susceptibility to End-Stage Renal Disease in Cantonese Patients Awaiting Kidney Transplantation
por: Cao, Qiong, et al.
Publicado: (2014)

Prognostic value of combined preoperative fibrinogen and neutrophil–lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016)

Cell-Based Regenerative Therapy as an Alternative to Liver Transplantation for End-Stage Liver Disease: Experience from Iran
por: Malekzadeh, R., et al.
Publicado: (2010)

Malnutrition and sarcopenia predict post‐liver transplantation outcomes independently of the Model for End‐stage Liver Disease score
por: Kalafateli, Maria, et al.
Publicado: (2016)

Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions
por: Righi, Elda
Publicado: (2018)

Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada
por: Burak, Kelly W., et al.
Publicado: (2016)

Mortality scoring systems for liver transplant recipients: before and after model for end-stage liver disease score
por: Chung, Yang-Hoon, et al.
Publicado: (2023)

Survival prediction among patients with non-cancer-related end-stage liver disease
por: Tsai, Yi-Wen, et al.
Publicado: (2018)

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
por: Guo, Yong-zhe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d97521s1dd205tvh7veeob83lm